E110

E110

SCHEMBL323402

O=S(=O)([O-])c1ccc(/N=N/c2c(O)ccc3cc(S(=O)(=O)[O-])ccc23)cc1.[Na+].[Na+]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of E110. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB known ✓ P10828 3/20 1.00
▸ PTGS1 known ✓ P23219 1/20 0.43
▸ PTGS2 known ✓ P35354 1/20 0.43
▸ CYP1A2 P05177 2/20 0.67
▸ CYP2C9 P11712 2/20 0.67
▸ PTPN1 P18031 2/20 0.58
▸ MAPT P10636 5/20 0.58
▸ KMT2A Q03164 4/20 0.58
▸ MEN1 O00255 3/20 0.58
▸ APP P05067 1/20 0.57
▸ PLCG1 P19174 1/20 0.53
▸ TSHR P16473 1/20 0.51
▸ PTPRA P18433 1/20 0.51
▸ PTPRB P23467 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ HIF1A Q16665 1/20 0.51
▸ RAPGEF4 Q8WZA2 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ TDP1 Q9NUW8 4/20 0.48
▸ GAA P10253 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
E110 SCHEMBL29350765 1.00 THRB (1.00) THRBCYP1A2CYP2C9PTPN1MAPT
E110 SCHEMBL13276157 1.00 THRB (1.00) THRBCYP1A2CYP2C9PTPN1MAPT
E110 SCHEMBL142458 1.00 THRB (1.00) THRBCYP1A2CYP2C9PTPN1MAPT
SCHEMBL12760915 0.97 THRB (0.95) THRBCYP1A2CYP2C9PTPN1MAPT
SCHEMBL3196947 0.93 THRB (0.88) THRBCYP1A2CYP2C9PTPN1MAPT
SCHEMBL29489969 0.93 THRB (0.88) THRBCYP1A2CYP2C9PTPN1MAPT
SCHEMBL4808237 0.93 THRB (0.88) THRBCYP1A2CYP2C9PTPN1MAPT
SCHEMBL30341067 0.92 THRB (0.85) THRBCYP1A2CYP2C9PTPN1MAPT
SCHEMBL9343017 0.92 THRB (0.85) THRBCYP1A2CYP2C9PTPN1MAPT
SCHEMBL29394731 0.92 THRB (0.85) THRBCYP1A2CYP2C9PTPN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3817 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026087310-A1 COMPOSITION, CONSUMABLE AND METHODS GIVAUDAN SA (CH) 2026-04-30 — — WO claimed
EP-4720318-A1 METHODS AND COMPOSITIONS FOR THE PRODUCTION OF GLYOXAL Solugen, Inc. (US) 2026-04-08 — — EP claimed
EP-4716527-A1 A MULTIPLE UNIT ORAL DOSAGE FORM OF DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE FREE OF TITANIUM DIOXIDE Italfarmaco SpA (IT) 2026-04-01 — — EP claimed
WO-2025229356-A1 ORAL HYDRATION SOLUTION AQABELA LTD (GB) 2025-11-06 — — WO claimed
EP-3389595-B1 COMBINATION OF POLYION COMPLEX PARTICLE AND NON-POLYMERIC ACID HAVING TWO OR MORE ACID DISSOCIATION CONSTANTS OREAL (FR) 2025-11-05 — — EP claimed
US-20250318553-A1 VEGETABLE AND FRUIT KABOB PET TREAT SPECTRUM BRANDS INC (US) 2025-10-16 — — US claimed
EP-3958926-B1 MULTIVASCULAR NETWORKS AND FUNCTIONAL INTRAVASCULAR TOPOLOGIES WITHIN BIOCOMPATIBLE HYDROGELS UNIV RICE WILLIAM M (US) 2025-08-20 — — EP claimed
US-20250186407-A1 TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING A MACROLIDE IMMUNOSUPPRESSANT NUCLEUS MEDICAL GMBH (DE) 2025-06-12 — — US claimed
US-20250178995-A1 COMPOSITIONS AND METHODS FOR THE PRODUCTION OF GLUCARIC ACID SOLUGEN, INC. (US) 2025-06-05 — — US claimed
WO-2025106816-A1 A HYDROGEL-BASED HETEROGENEOUS CATALYST MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2025-05-22 — — WO claimed
WO-2000030592-A1 PERMANENT, REMOVABLE TISSUE MARKINGS THE GENERAL HOSPITAL CORPORATION (US) 2000-06-02 — — WO claimed
EP-0966268-A1 CROSS-LINKED PLANT PROTEIN PARTICLES, IN PARTICULAR MICROPARTICLES OR NANOPARTICLES, PREPARATION METHOD AND COSMETIC, PHARMACEUTICAL OR FOOD COMPOSITIONS CONTAINING SAME COLETICA (FR) 1999-12-29 — — EP claimed
US-5912016-A ACRYLATING POLYFUNCTIONAL CROSSLINKING AGENTS FOR COSMETICS AND FOODS COLETICA (FR) 1999-06-15 — — US claimed
WO-1999003450-A1 CROSS-LINKED PLANT PROTEIN PARTICLES, IN PARTICULAR MICROPARTICLES OR NANOPARTICLES, PREPARATION METHOD AND COSMETIC, PHARMACEUTICAL OR FOOD COMPOSITIONS CONTAINING SAME COLETICA (FR) 1999-01-28 — — WO claimed
US-5545442-A Method for using a radiation cured drug release controlling membrane CIBA-GEIGY CORPORATION (US) 1996-08-13 — — US claimed
US-5532287-A Radiation cured drug release controlling membrane CIBA-GEIGY CORPORATION (US) 1996-07-02 — — US claimed
US-5300293-A Mixture of antigrowth agent and dextrin SUMITOMO CHEMICAL CO., LTD. (JP) 1994-04-05 — — US claimed
US-5096710-A Cockroaches, juvenile hormone or chitin synthesis inhibitor, dextrin, plant oil SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1992-03-17 — — US claimed
US-4985413-A Poison bait for control of noxious insects SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-01-15 — — US claimed
US-4834977-A Poison bait for control of noxious insects SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1989-05-30 — — US claimed
Send feedback